Saturday - January 03, 2026

2026 Golden Visa Update: Investment Migration Industry Faces Rising Wave of Sophisticated Fraud, Warns New Industry Report

As the global investment migration market continues its expansion beyond $20 billion in annual revenue, a comprehensive new analysis reveals an alarming surge in fraudulent schemes targeting unsuspecting investors seeking citizenship and residency through investment programs. The report exposes a … Continue reading

Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is gaining investor attention as a next-generation biopharmaceutical company developing advanced immune-strengthening therapeutics for some of the world’s most critical diseases, including HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, and Diabetes. The company’s intellectual … Continue reading